Back
Evotec SE 10K Form
Sell
39
EVO
Evotec SE
Last Price:
$4.4600
Seasonality Move:
14056.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EVO News And Ratings
See the #1 stock for the next 7 days that we like better than EVO
EVO Financial Statistics
Sales & Book Value
| Annual Sales: | $846M |
|---|---|
| Cash Flow: | $11.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.05 |
| Price / Book: | 1.46 |
Profitability
| EPS (TTM): | -0.52590 |
|---|---|
| Net Income (TTM): | $-185.6M |
| Gross Margin: | $189.5M |
| Return on Equity: | -15.99% |
| Return on Assets: | -7.98% |
Evotec SE Earnings Forecast
Key Evotec SE Financial Ratios
-
The Gross Profit Margin over the past 19 years for EVO is 22.40%.
-
The Selling, General & Administrative Expenses for EVO have been equal to 21.71% of Gross Profit Margin.
-
The Research & Development expenses have been 7.36% of Revenue.
-
The Interest Expense is -13.99% of Operating Income.
-
The Net Earning history of EVO is -10.74% of Total Revenues.
-
Per Share Earnings over the last 19 years have been positive in 11 years.
Evotec SE Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | EVO |
| Website: | evotec.com |
Debt
| Debt-to-Equity Ratio: | 0.49 |
|---|---|
| Current Ratio: | 2.09 |
| Quick Ratio: | 1.82 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |